e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How to prevent VTE in COVID-19 patients?: Chinese & European perspectives
Chen Xiangqi (Fujian, China), Niki Ubags (Lausanne, CH), Sheila Ramjug (Manchester, United Kingdom)
Source:
ERS webinar 2020: How to prevent VTE in COVID-19 patients?: Chinese & European perspectives
Number:
0
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Chen Xiangqi (Fujian, China), Niki Ubags (Lausanne, CH), Sheila Ramjug (Manchester, United Kingdom). How to prevent VTE in COVID-19 patients?: Chinese & European perspectives. ERS webinar 2020: How to prevent VTE in COVID-19 patients?: Chinese & European perspectives
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Paul Thomas - 04.07.2020 18:15
Absolute excellent lecture
Paul Thomas - 04.07.2020 18:15
Absolute excellent lecture
Khalid Hassan Ba-Msahell - 26.06.2020 00:59
Thanks
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical case discussion: ERS statement on long COVID-19 follow-up
Occupational COVID-19
TB and COVID-19 – a dangerous new combination?
Related content which might interest you:
Venous thromboembolic (VTE) in patients with ALS: an incidence study
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021
Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Prophylaxis of venous thromboembolism : what is new?
Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress
Year: 2019
Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Venous thromboembolism prophylaxis in hospitals in China: a nationwide survey
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020
Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Thrombophilias in 60 Bulgarian patients with "idiopathic" venous thromboembolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
Recurrence patterns for venous thromboembolism - who is most at risk?
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Venous thromboembolism in patients immobilized at home
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Treatment of venous thromboembolism in cancer patients with tinzaparin beyond 6 months. TiCAT study
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
The diagnosis of malignancy following a venous thromboembolic event - how high is the risk?
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review
Source: Eur Respir J 2015; 45: 201-210
Year: 2015
Risk factors in patients with venous thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 239s
Year: 2002
Venous thromboembolism (VTE) prophylaxis in acute medical admissions to a university hospital
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL)
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Age is a major risk factor of venous thromboembolism (VTE)
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011
Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer.
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Search predictive factors of recurrence in venous thromboembolic disease associated with cancer after withdrawal of the anticoagulation. HISPALIS study
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Venous thromboembolism and pulmonary cancer: A ten years series
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept